The role of therapeutic drug monitoring in the management of patients with human immunodeficiency virus infection.
about
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patientsEndosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma.The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.In vitro activity of antiretroviral drugs against Plasmodium falciparumMagnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapyCurrent practices in laboratory monitoring of HIV infection.A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study.Nevirapine inhibits the anti-HIV activity of CD8+ cellsAntiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management.Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old.Dosing antiretroviral medication when crossing time zones: a review.Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy.Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.Enteral Administration of Twice-Daily Dolutegravir and Rilpivirine as a Part of a Triple-Therapy Regimen in a Critically Ill Patient with HIV.Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations.Current and Future Status of Therapeutic Drug Monitoring in the Treatment of IBD.Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution.Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism.Unexpected vertical transmission of HIV infection.Are lopinavir and efavirenz serum concentrations in HIV-infected children in the therapeutic range in clinical practice?Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world.Educational and organizational interventions to improve the usefulness of clinical pharmacological advice for personalized drug dosing based on therapeutic drug monitoring.Quantifying the activity of anti-HIV treatment in silico
P2860
Q33365566-48BD11B7-9718-4454-8BBD-A5C7276F2E72Q33927106-63657746-839E-4F39-A214-9B6059BC3F2BQ34059457-D7F77DE5-34D5-41A5-AC5D-8B786A31D644Q34499668-21C9B1FA-3081-4871-862C-03B0103EE434Q35023687-D2197F45-4175-4275-B89A-35A49F7A3B53Q35363679-93F96E4C-7C4E-41BF-8191-778AEDADA6BFQ35703450-D4D6316C-9D53-43E9-8484-515F57C156CCQ35770853-BCC99C35-85FA-49D3-8805-E2235D4599E0Q36263781-09F67410-2934-4EE8-9D23-4ECB29180A61Q36843910-764A3BE5-BCE9-44E5-AF12-FAB0E80338B4Q37378110-A5479230-5268-4B30-BD4E-7E9F4E6708C5Q38377051-1B488872-3CD1-46D0-B06F-30E6A91366D5Q38674015-59A1E431-1231-455C-A154-263E4420D7B3Q38920747-ED781590-823E-475E-A68E-53E4BAE84792Q38954109-D9699C3F-DA5B-4D12-AD89-936EE66B9933Q38960937-BC2604D2-CA1E-43B3-A667-5FEF7B443881Q39074109-59560C53-CC12-4F86-B25A-0A2E70FAB0E1Q39278646-75B5731A-89BE-40FD-B5AC-2F96E4F1A95CQ41905223-E3DE6DEC-CED1-451A-AB2A-B405A71EFA1DQ42251901-712E4CA4-641A-4C42-BACA-B2783FBDDE2CQ42263864-0EF79525-46B9-465F-BE5E-934D3AB62461Q46904130-04D01545-1F4F-45C6-9E57-E5B405E88A9DQ50140688-F8C87829-35E1-4B6A-B883-A9C0333C5213Q51743667-72E4E281-309C-4E40-BC84-A8354C4AE5CCQ56962315-7E12F139-5D89-4BCC-8820-02F3403CF9AF
P2860
The role of therapeutic drug monitoring in the management of patients with human immunodeficiency virus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of therapeutic drug m ...... unodeficiency virus infection.
@en
The role of therapeutic drug m ...... unodeficiency virus infection.
@nl
type
label
The role of therapeutic drug m ...... unodeficiency virus infection.
@en
The role of therapeutic drug m ...... unodeficiency virus infection.
@nl
prefLabel
The role of therapeutic drug m ...... unodeficiency virus infection.
@en
The role of therapeutic drug m ...... unodeficiency virus infection.
@nl
P1476
The role of therapeutic drug m ...... munodeficiency virus infection
@en
P2093
Bernd Rosenkranz
Hartwig Klinker
P304
P356
10.1097/FTD.0B013E31821B42D1
P577
2011-06-01T00:00:00Z